Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development

Cellular levels of NMT in T. cruzi life-cycle stages Immunoblots of

Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development

Water molecules in PDZ domains HTRA1, HTRA2, and HTRA3. Selectivity in

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development

ACS Infectious Diseases

Wellcome Centre for Anti-Infectives Research 6 year Report by Wellcome Centre for Anti-Infectives Research, Dundee - Issuu

NMT inhibition results in loss of the inner membrane complex and

Key needs to accelerate Cryptosporidium drug development.

Cryptosporidiosis Drug Discovery: Opportunities and Challenges

Contacts between SC-58272 and Nmt1p.a, Contact distances (Å). The

Frontiers Paving the Way: Contributions of Big Data to Apicomplexan and Kinetoplastid Research

Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetase

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development

Discovery of a Novel Class of Orally Active Trypanocidal N- Myristoyltransferase Inhibitors